Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.

Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new site revision label 'Revision: v3.4.2' and removed older revision notices 'v3.4.1' as well as a government funding status notice; these are routine site maintenance updates rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now displays a government funding notice and shows the updated revision label (v3.4.1) while removing the previous label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded the 'Show glossary' option and updated several page labels (capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'). The revision stamp was updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 shown on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedLocations section reorganized with new abbreviations BS, FI, MI, and VA; removal of the BS/FI/MI/VA location subsections and upgrade from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check92 days agoChange DetectedPage revision changed from v3.2.0 to v3.3.2; no study details or eligibility information were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.